Epigentek

Farmingdale, United States Founded: 2005 • Age: 21 yrs
Delivers comprehensive solutions for epigenetics-related research and drug discovery.

About Epigentek

Epigentek is a Healthcare company based in Farmingdale (United States) founded in 2005. It delivers comprehensive solutions for epigenetics-related research and drug discovery. It operates on a B2B model. Its focus areas include Biotechnology, Research and Development and Epigenetics Solutions. Its competitors include RareCyte, Sequenta and seqWell; 3 of its 3 listed competitors have raised funding.

Company details

Epigentek operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, research and development, and epigenetics solutions. Delivers comprehensive solutions for epigenetics-related research and drug discovery. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Competitors of Epigentek

Epigentek has 3 listed competitors in our database, 3 of them funded. They include RareCyte, Sequenta and seqWell.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
rarecyte.com2009Seattle, United States$114.33M54
Developer of technologies for the analysis of rare and single cells in the blood
sequenta.com2008San Francisco, United States$43.46M58
Immuno-sequencing products are developed for disease diagnostics and treatment.
seqwell.com2014Beverly, United States$24.51M30
NGS-based reagents and kits are supplied for life sciences research.
Premium access

Detailed competitors of Epigentek

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Epigentek

Websites that share an audience with Epigentek (epigentek.com).

Similar websites

Websites whose visitors overlap most with Epigentek. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
activemotif.com
99%
57.6K#613,526View details
mblintl.com
98%
6.7K#3,199,704View details
diagenode.com
85%
19.4K#1,415,645View details
vitrocell.com
83%
1.5K#12,693,960View details
chromocyte.com
83%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 13 similar websites and full traffic analytics for Epigentek

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Epigentek (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Epigentek

Premium access

Complete news archive for Epigentek

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Epigentek

Epigentek was founded in 2005.

Epigentek is headquartered in Farmingdale, United States. It is registered at Farmingdale, New York, United States.

Epigentek operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, research and development, and epigenetics solutions. Delivers comprehensive solutions for epigenetics-related research and drug discovery. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Epigentek's top competitors include seqWell, RareCyte and Sequenta.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available